Clinical trial
Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim
NCT00280787 · UNC Lineberger Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00280787 |
|---|---|
| Title | Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim |
| Official title | LCCC 0215: Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim Support Followed by Conformal Radiotherapy and Paclitaxel/Carboplatin/ZD1839 in Locally Advanced Unresectable Stage IIIA/B Non-Small Cell Carcinoma of the Lung |
| Lead sponsor | UNC Lineberger Comprehensive Cancer Center, Other |
| Collaborators | AstraZeneca Industry Amgen |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Paclitaxel, Carboplatin, CPT-11, Pegfilgrastim, Conformal radiotherapy |
| Enrollment | 24 |
| Start date | Nov 1, 2003 |
| Primary completion | Jan 1, 2006 |
| Completion | Oct 1, 2010 |
| First posted | Jan 23, 2006 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: